OxLDL-stimulated macrophage exosomes promote proatherogenic vascular smooth muscle cell viability and invasion via delivering miR-186–5p then inactivating SHIP2 mediated PI3K/AKT/mTOR pathway-Reference-Cited by-全球学者库

OxLDL-stimulated macrophage exosomes promote proatherogenic vascular smooth muscle cell viability and invasion via delivering miR-186–5p then inactivating SHIP2 mediated PI3K/AKT/mTOR pathway

Published:2022-06 Issue: Volume:146 Page:27-37
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Ren Lingyun,Chen Shanshan,Yao Dan,Yan Hong

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference29 articles.

1. Migrasomes and exosomes; different types of messaging vesicles in podocytes;Ardalan;Cell Biol. Int,2021

2. Macrophages in Atherosclerosis Regression;Barrett;Arterioscler. Thromb. Vasc. Biol.,2020

3. PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1;Benkirane;Am. J. Physiol. Heart Circ. Physiol.,2006

4. High glucose macrophage exosomes enhance atherosclerosis by driving cellular proliferation & hematopoiesis;Bouchareychas;iScience,2021

5. Macrophages in atherosclerosis, first or second row players?;Checkouri;Biomedicines,2021

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OxLDL-Stimulated Macrophages Transmit Exosomal MicroRNA-320b to Aggravate Viability, Invasion, and Phenotype Switching via Regulating PPARGC1A-Mediated MEK/ERK Pathway in Proatherogenic Vascular Smooth Muscle Cells;The Tohoku Journal of Experimental Medicine;2024

2. Roles of extracellular vesicles derived from immune cells in atherosclerosis;Extracellular Vesicle;2023-12

3. Advances in the study of exosomes in cardiovascular diseases;Journal of Advanced Research;2023-12

4. Based on network pharmacology and molecular docking to explore the molecular mechanism of Ginseng and Astragalus decoction against postmenopausal osteoporosis;Medicine;2023-11-17

5. The Role of Macrophages in Atherosclerosis: Participants and Therapists;Cardiovascular Drugs and Therapy;2023-10-21